ACCESS Newswire

Photonis

30.7.2024 16:06:45 CEST | ACCESS Newswire | Press release

Share
Photonis Showcases Advanced Nuclear Instrumentation Solutions at Utility Working Conference

MARCO ISLAND, FL / ACCESSWIRE / July 30, 2024 / Photonis, part of Exosens, a leading global provider of neutron and gamma detectors for the nuclear industry, announces its participation at the American Nuclear Society's Utility Working Conference and Vendor Technology Expo from August 4-7, 2024, in Marco Island, Florida. This event marks Photonis' strategic initiative to expand its presence in the U.S. market, showcasing its commitment to delivering high-quality, customized solutions tailored to the unique needs of the nuclear industry.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.
Photonis at UWC

With over 50 years of experience designing and manufacturing nuclear instrumentation for French nuclear power plants and research programs, Photonis brings a wealth of expertise to the American market. The company's comprehensive catalog of nuclear components includes market-leading technology such as High-Temperature In-Core and Ex-Core Fission Chambers, Miniature Gamma Ionization Chambers, and High-Sensitivity Boron-Lined Proportional Counters. Also featured are Mineral Insulated Cable Extensions and Connectors, highlighting Photonis' capability in product development and adaptation.

This extensive experience and innovative product range have earned Photonis a reputation as a trusted partner in the nuclear industry, with customers relying on its nuclear instrumentation in over 180 nuclear power plants worldwide. Additionally, Photonis is a critical component supplier for the French Alternative Energies and Atomic Energy Commission (CEA), further solidifying its reputation as a leading provider of high-quality nuclear detection solutions.

Photonis' neutron and gamma detectors play a crucial role in ensuring safety and control of nuclear reactors, fuel reprocessing plants, radioactive waste storage, and nuclear research facilities worldwide. By expanding its presence in the U.S. market, Photonis aims to establish itself as a trusted partner capable of delivering high-quality, tailored solutions that meet the evolving needs of industry stakeholders.

"We are thrilled to participate in the ANS Utility Working Conference and introduce our advanced nuclear instrumentation solutions to the U.S. market. Photonis is dedicated to meeting the stringent safety and regulatory requirements of the nuclear industry and to becoming one of the major solutions providers in the North American market. We look forward to engaging with U.S. customers and demonstrating how our technologies can enhance the safety and efficiency of their operations," said Ulrich Laupper, President and Executive General Manager of the Ultimate Detection Business Unit of Exosens.

The company's commitment to excellence is underscored by its dedicated Research and Development team, operating under ISO9001, ISO19443, RCCE (EDF Rules), ASME NQA-1, and HAF604 certifications, ensuring rigorous quality standards across all operations.

Attendees of the ANS Utility Working Conference are invited to visit Photonis at booth #105 to explore its wide range of innovative nuclear instrumentation solutions and discuss partnership opportunities.

ABOUT PHOTONIS:

Photonis is a leading product brand of Exosens, a high-tech company with more than 85 years of experience in the innovation, development, manufacture and sale of high-end electro-optical technologies. Photonis offers its customers photo-detection and low-light conditions imaging solutions for extremely demanding environments such as Defense & Security, Nuclear Safety, Life Science and Industrial & Non-Destructive testing. Photonis is internationally recognized as a leading brand and a major innovator in its fields with production and R&D sites in Europe and North America.

For more information: exosens.com.

Contact Information:

Sales Manager
Nuclear Instrumentation Sales Manager - North America
nuclearsales@exosens.com
508-744-8769

SOURCE: Photonis Scientific, Inc.

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Proxymity Unveils MiKaDiv Compliance Solution for Issuers Ahead of New German Tax Regime18.11.2026 08:30:00 CET | Press release

FRANKFURT AM MAIN, DE / ACCESS Newswire / November 18, 2026 / Proxymity, the digital investor communications platform, is set to launch its MiKaDiv Compliance Solution as Germany's new dividend reporting regime takes effect in January 2027, giving German issuers a single place to manage their new obligations to the Federal Central Tax Office (BZSt). From 1 January 2027, dividends paid by listed German companies will carry an additional reporting step: the company must pass details of its shareholders to the BZSt. SRD II, transposed into German law under Section 67d of the German Stock Corporation Act, (AktG) took effect in 2020 and gave issuers the right to identify their investors, including foreign investors held through nominee accounts. MiKaDiv now makes it a requirement. The first reports are expected early in the 2027 AGM season, as issuers seek approval for their dividends. Proxymity is the leading provider of shareholder identification to German issuers, handling more than 40%

QorusDocs Named LegalTech AI Platform of the Year and Ranked No. 1 Proposal Management Software17.11.2026 15:00:00 CET | Press release

BELLEVUE, WA / ACCESS Newswire / November 17, 2026 / QorusDocs, the pursuit intelligence platform trusted by dozens of Am Law 200 and Global 200 law firms, today announced it has been named LegalTech AI Platform of the Year in the seventh annual LegalTech Breakthrough Awards program and ranked the No. 1 proposal management solution by Info-Tech Research Group's SoftwareReviews, based on verified end-user reviews. The recognitions cap a year of rapid growth in legal for QorusDocs, which forecasts it will double its annual recurring revenue (ARR) from law firms in the next 12 months by adding more high-profile firms to its list of big law customers, which already includes DLA Piper, Baker McKenzie, Herbert Smith Freehills Kramer and Womble Bond Dickinson. Firms are moving AI beyond research and drafting and into business development, where a winning pitch depends on the best representative matters, strong attorney biographies and winning pitch strategies: knowledge general AI tools lack.

Freezz Italia Awarded ESA Contract for IRIS(2) Low-LEO Pre-Operational and De-Risk Activities17.11.2026 14:00:00 CET | Press release

CORTONA, IT / ACCESS Newswire / November 17, 2026 / Freezz Italia has been awarded a contract by the European Space Agency (ESA), as prime contractor leading a European industrial consortium, for the Consolidation Phase of the IRIS² Low-LEO Pre-Operational and De-Risk Activities, part of the ESA Programme Related to EU Secure Connectivity. The activity will further mature Friisat, Freezz's satellite system architecture conceived specifically for operation in Very Low Earth Orbit (VLEO) and designed for future broadband Direct-to-Device (D2D) connectivity within the 3GPP 5G/6G Non-Terrestrial Network (NTN) framework. Under this ESA contract, Freezz Italia will consolidate the mission and system architecture, adapting Friisat's existing commercial design to meet the requirements of an IRIS²-compatible solution, including future governmental broadband Direct-To-Device secure-connectivity services. The work will address the system and service concepts, architecture and interfaces, security

International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital17.11.2026 11:00:00 CET | Press release

PARIS, FR / ACCESS Newswire / November 17, 2026 / Opti Digital, the leading AdTech company specialising in publisher revenue optimisation, today announced the results of its collaboration with International Business Times UK, an international digital news brand delivering business, markets, technology and current affairs coverage to a global readership. Operating in a fast-moving news environment, International Business Times UK continuously explores opportunities to increase the value of its digital audience while maintaining control over advertising quality and user experience. The publisher identified an opportunity to generate incremental revenue from its existing audience and inventory through a monetisation experience that could be tested progressively and scaled across a broader share of its inventory. "We were looking for ways to generate more value from our existing inventory, and the performance quickly demonstrated the potential of the new experience. It has become a meaning

OBI Pharma Signs Collaboration and License Agreement with Novartis16.11.2026 09:10:00 CET | Press release

TAIPEI, TW / ACCESS Newswire / November 16, 2026 / OBI Pharma, Inc. (4174.TWO) ("OBI") announced that it has entered into a Collaboration and License agreement with Novartis Pharma AG ("Novartis") to develop next generation Antibody-Drug-Conjugates (ADCs) with novel payloads, using OBI's suite of platform technologies. Under the terms of the agreement, Novartis will receive worldwide rights to OBI's related patents and know-how using its ADC platform technologies on an exclusive basis for selected, undisclosed Novartis payload classes. In parallel, under the collaboration OBI will evaluate novellinker approaches with the Novartis payloads. Novartis will further have the option to expand the agreement to include additional novel payload classes. This agreement marks an important milestone for OBI and underscores the value of its differentiated ADC technology platform. The agreement recognizes the potential of OBI's proprietary technologies, including GlycOBI®, EndoSymeOBI®, HYPrOBI®, an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye